Cart
sales@molnova.com
GW297361
CAS No. 388627-21-2
GW297361( —— )
Catalog No. M36628 CAS No. 388627-21-2
GW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 247 | In Stock |
|
| 10MG | 371 | In Stock |
|
| 25MG | 591 | In Stock |
|
| 50MG | 768 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | 1414 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGW297361
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.
-
DescriptionGW297361 is an oxindole CDK inhibitor that elicits a Pho85-selective response in cells. GW297361 inhibits yeast Cdk1 and Pho85 with IC50s of 20 nM and 400 nM in vitro, respectively.
-
In VitroWestern Blot Analysis Cell Line:YRP1 cells Concentration:20 μM Incubation Time:20 μM Result:An intermediate level of the Orc6 was converted to the faster-migrating isoform (lower:upper = 2:1).
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR | Src | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number388627-21-2
-
Formula Weight372.42
-
Molecular FormulaC16H12N4O3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (268.51 mM; Ultrasonic )
-
SMILESC(NC1=CC=C(S(N)(=O)=O)C=C1)=C2C=3C4=C(C=CC3NC2=O)N=CS4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kung C, et al. Selective kinase inhibition by exploiting differential pathway sensitivity. Chem Biol. 2006 Apr;13(4):399-407.?
molnova catalog
related products
-
VEGFR2-IN-1
VEGFR2-IN-1 is a selective and potent VEGFR2 inhibitor with antitumor activity that inhibits cell proliferation and migration and can be used in the study of breast cancer.
-
BFH-772
A potent, selective and orally active VEGFR2 tyrosine kinase inhibitor with IC50 of 3 nM.
-
Brivanib
A dual inhibitor of VEGFR2 and FGFR1 with IC50 of 25 nM and 148 nM respectively.
